Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 6/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.41 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12966654 | 0.93 | GAA (0.54) | GAANPSR1MAPTNPC1RAB9A | |
| SCHEMBL12966547 | 0.86 | ALDH1A1 (0.46) | MAPTNPC1RAB9ALTA4HKDM4E | |
| SCHEMBL24507142 | 0.82 | LTA4H (0.52) | MAPTLTA4HL3MBTL1CYSLTR2CYSLTR1 | |
| SCHEMBL12966549 | 0.82 | ALDH1A1 (0.48) | GAANPSR1MAPTNPC1RAB9A | |
| SCHEMBL13336518 | 0.77 | GAA (0.55) | GAANPSR1MAPTLTA4HL3MBTL1 | |
| SCHEMBL12966652 | 0.76 | MAPT (0.51) | GAANPSR1MAPTNPC1RAB9A | |
| SCHEMBL13177484 | 0.76 | GAA (0.54) | GAANPSR1MAPTLTA4HL3MBTL1 | |
| SCHEMBL7717973 | 0.75 | PPARD (0.50) | MAPTLTA4HCYSLTR2CYSLTR1ALDH1A1 | |
| SCHEMBL7717977 | 0.75 | PPARD (0.50) | MAPTLTA4HCYSLTR2CYSLTR1ALDH1A1 | |
| SCHEMBL12967065 | 0.74 | CTRC (0.48) | GAANPSR1MAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012130850-A1 | TISSUE TARGETING BY MEANS OF ONCOCIDAL BRIDGED DIPHENYL DERIVATIVES FOR THE SELECTIVE TREATMENT OF SEXUAL ORGAN TUMORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-10-04 | — | — | WO | disclosed |